Rchr
J-GLOBAL ID:201801011957087280   Update date: Sep. 18, 2024

Tatekawa Shotaro

タテカワ ショウタロウ | Tatekawa Shotaro
Affiliation and department:
Other affiliations (1):
Homepage URL  (1): http://www2.med.osaka-u.ac.jp/radonc/
Research field  (1): Radiology
Research theme for competitive and other funds  (9):
  • 2023 - 2026 Clonal Hematopoiesis による放射線肺臓炎重症化機序の解明
  • 2024 - 2025 Clonal Hematopoiesis による放射線肺臓炎重症化機序の解明
  • 2024 - 2025 Clonal Hematopoiesisによる放射線肺臓炎重症化機序の解明
  • 2020 - 2023 The relationships of tumor micro environment and radiation resistance with clonal hematopoiesis
  • 2020 - 2022 Clonal hematopoiesis による腫瘍微小環境の変化と放射線抵抗性
Show all
Papers (37):
  • Kazuhiko Hayashi, Hiroshi Ishikawa, Kei Fujiwara, Masataka Nakai, Hitoshi Ono, Yasutoshi Fumimoto, Nobuyuki Tamaki, Shotaro Tatekawa, Takero Hirata, Toru Kimura, et al. Stereotactic Ablative Radiotherapy for Early-stage Lung Cancer in Patients With Left Ventricular Assist Device: A Case Series. Anticancer research. 2024. 44. 9. 4113-4117
  • Mengyang Ju, Kazumasa Minami, Shohei Katsuki, Wataru Takenaka, Shotaro Tatekawa, Keisuke Tamari, Masahiko Koizumi, Yutaka Takahashi, Kazuhiko Ogawa. Synergistic Effects of Melatonin on Radiosensitization in Carbon-ion Radiotherapy. Anticancer research. 2024. 44. 8. 3295-3306
  • Tomoaki Hara, Sikun Meng, Hiromichi Sato, Shotaro Tatekawa, Kazuki Sasaki, Yu Takeda, Yoshiko Tsuji, Yasuko Arao, Ken Ofusa, Toru Kitagawa, et al. High N6-methyladenosine-activated TCEAL8 mRNA is a novel pancreatic cancer marker. Cancer science. 2024
  • Sikun Meng, Tomoaki Hara, Hiromichi Sato, Shotaro Tatekawa, Yoshiko Tsuji, Yoshiko Saito, Yumiko Hamano, Yasuko Arao, Noriko Gotoh, Kazuhiko Ogawa, et al. Revealing neuropilin expression patterns in pancreatic cancer: From single-cell to therapeutic opportunities (Review). Oncology letters. 2024. 27. 3. 113-113
  • Yuki Ozato, Tomoaki Hara, Sikun Meng, Hiromichi Sato, Shotaro Tatekawa, Mamoru Uemura, Takeshi Yabumoto, Shizuka Uchida, Kazuhiko Ogawa, Yuichiro Doki, et al. RNA methylation in inflammatory bowel disease. Cancer Science. 2024
more...
MISC (32):
  • 平田岳郎, 立川章太郎, 林和彦, 玉利慶介, 瀬尾雄二, 礒橋文明, 清水伸一, 小川和彦. Stereotactic ablative radiotherapy for prostate cancer: current status and future perspective. 日本放射線腫瘍学会高精度放射線外部照射部会学術大会プログラム・抄録集. 2023. 36th
  • 瀬尾雄二, 小野仁志, 瀬戸口映, 立川章太郎, 林和彦, 玉利慶介, 平田岳郎, 礒橋文明, 清水伸一, 小泉雅彦, et al. 頭頸部放射線治療による耳下腺・顎下腺の経時的体積変化. 頭頸部癌. 2023. 49. 2
  • 小野仁志, 瀬尾雄二, 瀬戸口映, 立川章太郎, 林和彦, 玉利慶介, 平田岳郎, 礒橋文明, 清水伸一, 小泉雅彦, et al. 早期声門癌に対する週6回加速照射法の治療成績. 頭頸部癌. 2023. 49. 2
  • 玉利慶介, 立川章太郎, 瀬尾雄二, 瀬尾雄二, 林和彦, 福角隆仁, 田中秀憲, 鈴木基之, 江口博孝, 竹中幸則, et al. 血液中のPDL1測定による頭頸部癌放射線治療後の予後予測. 頭頸部癌. 2023. 49. 2
  • Shohei Katsuki, Yutaka Takahashi, Keisuke Tamari, Kazumasa Minami, Wataru Takenaka, Junya Yamamoto, Hideki Matsutani, Shotaro Tatekawa, Kazuhiko Ogawa, Masahiko Koizumi. Radiation therapy enhances systemic antitumor efficacy in PD-L1 therapy regardless of sequence in murine osteosarcoma. CANCER SCIENCE. 2022. 113
more...
Professional career (1):
  • 博士(医学) (京都府立医科大学)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page